antibodies were found to decline significantly faster in HIV seropositive than seronegative children. 2 The effect of HIV infection on measles immunity needs clarification in both developing and developed nations due to differences in immunization schedules and population characteristics. In developing countries such as Uganda, children receive measles vaccination as a single dose at or after 9 months of age instead of 12-15 months, and a monocomponent measles vaccine is used instead of a measles, mumps and rubella combined vaccine. Protein-energy malnutrition, common in developing nations, may also interact with HIV infection to impact the immune response to measles vaccination. To study this, we conducted a cross-sectional study in Kampala, Uganda, and compared measles IgG antibody levels in HIV-1 infected and uninfected children. We further sought to assess the influence of nutritional status on the association between HIV infection and measles antibody response.
Materials and Methods
The study population comprised children attending the general paediatric clinic at New Mulago teaching hospital and a paediatric HIV clinic at Old Mulago hospital in Kampala, the capital of Uganda. The study was approved by the Institutional Review Board of University Hospitals of Cleveland, and the Uganda National Council of Science and Technology. Subjects were enrolled from June to August, 1995. We studied a consecutive sample of children attending the two clinics after obtaining informed consent from parents. The eligibility criteria were: (1) aged between 15 months and 3 1 ⁄2 years; (2) full vaccination against measles; (3) no history of clinical measles, tuberculosis or cancer; and (4) no use of immunosuppressive drugs for more than 2 weeks in the previous 6 months. Full measles vaccination in Uganda is one dose of single antigen measles vaccine at у9 months, or 2 doses at 6 and у12 months. Of our 243 study participants, only three received the 2-dose schedule.
Data were collected by two trained physicians and included the child's age, dates for measles vaccination, and type of vaccination clinic which was located in a permanent health clinic or as part of a mobile outreach programme. These were obtained from the parent and verified from the child's health card. Additional variables included demographics, a history of measles in the family in the month prior to the study, number of children living in the home other than the subject, and number of families in the compound in which the child resided. A compound is a group of contiguous homes that share a common yard. Nutritional anthropometric measurements included height and weight. Body weight was measured using a spring scale to the nearest 100g; an average of two readings was used in the analysis. The height was measured to the nearest mm by calibrated height/length boards; two readings were averaged. Weightfor-height z-scores (WHZ) and height-for-age z-scores (HAZ) adjusted for age and sex were computed using the EPINUT anthropometry program of Epi Info. 3 For height and weight, children were removed from the scale and board, respectively, between measurements. Based on recommendations from the World Health Organization, 4 WHZ Ͻ-2 standard deviations (SD) of the reference population median was defined as wasting, a surrogate for inadequate weight gain or for weight loss. Similarly, a HAZ Ͻ-2 SD was defined as stunting (reduced linear growth), a surrogate for chronic poor nutrition. 4 Paediatric AIDS was defined according to criteria developed by the AIDS Control Program in Uganda. 5 We drew venous blood from each child for HIV and measles serology. HIV-1 serostatus was determined by duplicate enzyme-linked immunosorbent assays (ELISA) using two different kits (Cambridge Biotech HIV-1, UK, and Wellcome Uniform 2, Organon Teknika). A 10% random sample was validated by Western blot. Results of the three were concordant for all triplet tests. Measles IgG Microassay (Diamedix Corporation), a quantitative ELISA test, was used to measure measles antibody levels. 6 Measles antibody levels were recorded as ELISA units per ml of blood (EU/ml). Measles antibody levels were defined as 'low' and therefore unprotective if Ͻ15 EU/ml, and 'protective' if у15 EU/ml. 6 Univariate comparisons of variables between children with low and protective measles antibody levels and between the HIV-1 infected and uninfected children, as defined by serologic status at 15 months or older, were done by Fisher's exact test, χ 2 test, or Wilcoxon rank sum test. Proportions and medians are reported for categorical and continuous variables, respectively. Variables significantly associated with low measles antibodies in univariate analysis, together with their interaction terms with HIV, were included in multiple logistic regression models to find predictors of low measles antibodies adjusted for confounders. Statistical significance was set at P Ͻ 0.05, and odds ratio (OR), 95% confidence intervals (CI), P-values, and β-coefficients were calculated. SAS was used for all analyses.
Results
Of 251 eligible children, 243 (97%) were enrolled in the study after parental consent. The participants did not differ from nonparticipants (n = 8) with regard to sex, age, time since vaccination, number of families in the compound, measles in the home, and type of vaccination clinic, though the number of children in the home was significantly higher for participating children. A total of 243 subjects, of whom 50 (21%) were HIV-1 seropositive and 193 (79%) seronegative, were studied. Infected subjects did not exhibit clinical stigmata of AIDS. Subjects were between 16.8 and 41.3 months old, and 38.7% were male. Eighty-nine per cent and 11% of subjects came from New and Old Mulago clinics, respectively; we did not consider clinic of care in the analysis because it is highly correlated with HIV infection. All HIV-1 seropositive subjects were HIV-1 infected because all were older than 15 months by which time transplacental antibodies have disappeared. Prevalence of HIV-1 infection was 14% (30) in the New Mulago group and 77% (20) in the Old Mulago group. For all study subjects, 146 (60%) had measles antibody levels у15 EU/ml, leaving 97 (40%) with measles levels Ͻ15 EU/ml, and thus unprotected against measles. (See Table 1 for a description of the study population.)
HIV infection, stunting, and Ͻ3 children in the home were associated with low antibody levels ( Table 2) . Male gender and a history of measles in the home were inversely associated with low measles antibodies, but were of borderline statistical significance. These two variables were included in the multivariable analysis because earlier studies have documented sex differences in immune response, 7 and exposure to measles was expected to stimulate an anamnestic response in previously vaccinated individuals. Vaccination at a mobile clinic had a significant association with higher measles antibodies. Time since vaccination (months) was not associated with measles antibody levels.
The HIV-infected group had significantly lower median measles antibody levels, and a higher proportion of children with measles antibody levels below 15 EU/ml, compared with the uninfected group (Table 3) . HIV-infected children were more likely to exhibit wasting, to be stunted, and to live in smaller compounds (Ͻ3 families). We found that stunting, Ͻ3 children in the household, lack of previous exposure to measles, and being female were associated with low or undetectable measles antibody levels. Table 4 shows predictors of low measles antibodies in a logistic model containing both HIV and stunting. The odds ratios for low measles antibody response were greater than one for both HIV infection and stunting, but neither was statistically significant (P Ͼ 0.10). Fewer than 3 children in the home was the only significant predictor of low measles antibodies. However, HIV infection and stunting were strongly related (univariate OR = 6.62, P Ͻ 0.0001). This strong association may have blunted the effect of both variables on low measles antibodies when both were included in the regression model. Therefore, backward elimination logistic regression analysis was done to determine which variable had the stronger independent impact on measles antibodies. In this stepwise model, stunting and Ͻ3 children were the only two variables selected; HIV infection did not enter this model (Table 5) .
We removed HIV infection from the model in Table 4 and obtained final results in Table 6 . Stunting, female gender, Ͻ3 children in the home, and lack of exposure to measles in the previous month were associated with low measles antibodies. The latter two predictors very likely decrease the possibility of anamnestic responses which may occur in the absence of clinical illness. 8, 9 Discussion Our study is the first to assess the effect of HIV infection together with nutritional status on measles immunity in a developing country. It is also one of the largest to date to explore the association of HIV and measles antibodies in children. We found that stunting, Ͻ3 children in the household, lack of previous exposure to measles, and being female were associated with inadequate vaccine response. The results of this analysis do not implicate HIV directly in the causal pathway toward low measles antibody levels after vaccination, but indicate that chronic malnutrition, as measured by stunting, causes the low antibody response. Stunting is a proxy for reduced linear growth due to chronic malnutrition or recurrent infections, and is common in HIV infection 10, 11 as shown in this study.
Malnutrition, regardless of its aetiology, is associated with poor response to measles vaccination. Lymphocyte depletion is a common sequellae of protein-energy malnutrition. 12, 13 It reduces the number of fully differentiated T lymphocytes 14 and reduces the helper to suppressor T lymphocytes ratio. 15 A reduction of antibody producing cells and in immunoglobulin production has also been reported. 16 There is also a reduction in secretory IgA antibody response to live attenuated measles and polio vaccines in undernourished children. 17 Pathophysiological mechanisms are known which support the strong association we found between HIV and stunting and HIV ON MEASLES ANTIBODIES IN CHILDREN 343 Vaccination at a mobile clinic (%) 13.6
Age at vaccination (median in months) 9.4
Time since vaccination (median in months) 14.0 Ͻ3 children in home (%) 48.6 Ͻ3 families in compound (%) 27.6
Completed immunization (%) 81.5
Measles in home in prior month (%) 7.0 chronic malnutrition. An HIV enteropathy characterized by villous atrophy, crypt hypertrophy and hyperplasia in the small intestine has been described in adults. 18, 19 The enteropathy is associated with fat malabsorption 20 and carbohydrate absorption disorders such as lactose intolerance 21 which may cause nutritional deficiencies. Enteric pathogens causing diarrhoea may also interfere with absorption of fats and carbohydrates, micronutrients, and amnio acids. 22 Small intestine autonomic neuropathy occurs in HIV-infected subjects and may alter intestinal motility and absorption of icons and water. 23 Tumour necrosis factor, or cachectin, is over expressed in HIV infection and may explain the chronic progressive weight loss in HIV. 24 Weight loss and growth abormalities may also result from inadequate food intake due to economic and social constraints in families of developing nations. This is common in homes with HIV-infected children whose frequent illnesses strain meagre resources, especially in urban areas where subsistence farming is not possible.
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Failure of HIV infection to predict low measles antibody levels directly in this study is consistent with previous work by Rudy et al., who found no difference in response to measles vaccination in 13 HIV-infected and 22 uninfected children, when vaccination was given before T-cell function diminished. 1 Our study contrasts that by Al-Attar et al. who found a significant decline in antibody levels in their HIV-infected patients. 2 However, the interval between vaccination and antibody measurement was longer in their study (mean of 19 months for HIV-infected group and 33 months for uninfected group) than our study which may account for the difference. Their study sample also included five subjects with clinical AIDS.
Inadequate power in our study precludes ruling out the possibility that HIV infection may impair antibody response as well as cause stunting. Also, our study could not separate primary vaccine failure from secondary vaccine failure because of its cross-sectional nature.
Possible biases in our study include selection bias, but this was small since non-participation was only 3%, and there were no differences in demographic and clinical characteristics between participants and non-participants. Survival bias may be present because children with AIDS in the same birth cohort as our sample may have died at an earlier age, but similar mean ages of our study and paediatric AIDS cases reported to the National AIDS Control Program (2.5 years for male and 2.9 years for females), 25 reduces the likelihood of survival bias. Temporal sequence bias may be present, but since our HIV-infected children were most likely vertically infected, HIV infection preceded measles vaccination.
In this study, we found that stunting was a predictor of poor measles antibody response after vaccination. Stunting is the result of chronic malnutrition which may be caused directly by HIV infection or by inadequate intake. Therefore, we hypothesize that HIV infection may act indirectly through chronic malnutrition to cause inadequate antibody response to measles vaccination in children in developing countries. To enhance the immunogenicity of measles vaccine, we recommend integration of nutrition and immunization programmes in developing countries. Children born to HIV-infected parents should be given nutritional support because of their vulnerability to malnutrition. HIV infection should not cause changes in measles vaccination programmes, but children born to HIV-infected parents should be vaccinated before profound immunosuppression (AIDS) develops.
